Mamento, Jiamela D.

HRN: 00-98-15  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/29/2022
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
07/29/2022
08/04/2022
IV
500mg
Q8
Intestinal Ameobiasis
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: